Product Images Teriflunomide

This appears to be a chart or graph showing the results of a study comparing the efficacy of 7mg and 14mg Teriflunomide Tablets to a placebo for a period of 108 weeks. The percentage of patients remaining in the study at each timepoint is shown, as is the number of participants at risk for the trial. The graph also highlights a statistically significant difference between the 14mg dose and the placebo. The rest of the text is not legible or coherent, so no further information can be gleaned.*

This text seems to be a chart or table comparing the efficacy of teriflunomide tablets with a placebo in reducing disability progression sustained for 12 weeks. The table provides data regarding the number of patients, percentage reduction in disability progression, and the number of patients at risk for a certain period. The 14 mg dosage of Teriflunomide has shown a statistically significant reduction in disability progression when compared to the placebo.*

This is a description of a medication called Teriflunomide, which comes in the form of tablets that contain 7mg of the drug. The medication is distributed by Breckenridge Pharmaceutical and manufactured by Centaur Pharmaceuticals Pvt. Ltd in Maharashtra, India. The medication is to be taken orally once daily, with or without food, and a medication guide should be given to each patient. The medication should be kept out of reach of children and stored between 20°C to 25°C or 68°F to 77°F. Excursions between 15°C to 30°C or 59°F to 86°F are permitted.*

This is a medication called Teriflunomide, which is manufactured by Centaur Pharmaceuticals Pvt. Ltd in India and distributed by Breckenridge Pharmaceutical in Berlin, CT. Each tablet contains 14 mg of Teriflunomide and is intended for oral consumption with or without food. The usual dose is one tablet per day, and a warning is given to keep the medication out of reach of children. A medication guide is provided with the medicine, and it is recommended to store it at a temperature between 20°C to 25°C, with excursions permitted between 15°C and 30°C.*